Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Akbarnejad Z et al. | 2017 | intact cell/cell culture, U87 (human glioblastoma cell line) | magnetic field, signals/pulses, 50/60 Hz | 5–10 mT |
| Alipour M et al. | 2022 | intact cell/cell culture, rat bone marrow-derived mesenchymal cells (BMSCs) | static magnetic field, magnetic field, 50/60 Hz, co-exposure | - |
| Amiri M et al. | 2018 | intact cell/cell culture, human glioblastoma cell line (U-87) | 50/60 Hz, static magnetic field, magnetic field, co-exposure, also other exposures without EMF | - |
| Amirinejad M et al. | 2024 | intact cell/cell culture, A172 and T98G (human glioblastoma cells) cell lines | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
| An GZ et al. | 2015 | intact cell/cell culture, BALB/3T3 cells (embryonal mouse fibroblasts) | magnetic field, 50/60 Hz | 2.3 mT |
| Ansari RM et al. | 2000 | intact cell/cell culture, human-hamster hybrid cells | magnetic field, 50/60 Hz, co-exposure | 100 µT |
| Aparicio-Bautista DI et al. | 2022 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, low frequency | - |
| Asadian N et al. | 2021 | intact cell/cell culture, rat bone marrow-derived mesenchymal stem cells | 50/60 Hz, magnetic field | 400 µT |
| Baharara J et al. | 2016 | intact cell/cell culture, A2780 cells (cisplatin-resistant human ovarian adenocarcinoma cells) | magnetic field, 50/60 Hz, co-exposure | 20 mT |
| Balbaa AO et al. | 2019 | - | 50/60 Hz, magnetic field, electric field, co-exposure | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
